Literature DB >> 10433234

Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors.

G Mbalaviele1, N Jaiswal, A Meng, L Cheng, C Van Den Bos, M Thiede.   

Abstract

Interactions between osteoclast progenitors and stromal cells derived from mesenchymal stem cells (MSCs) within the bone marrow are important for osteoclast differentiation. In vitro models of osteoclastogenesis are well established in animal species; however, such assays do not necessarily reflect human osteoclastogenesis. We sought to establish a reproducible coculture model of human osteoclastogenesis using highly purified human marrow-derived MSCs (hMSCs) and CD34+ hematopoietic stem cells (HSCs). After 3 weeks, coculture of hMSCs and HSCs resulted in an increase in hematopoietic cell number with formation of multinucleated osteoclast-like cells (Ocls). Coculture of hMSCs with HSCs, transduced with a retroviral vector that expresses enhanced green fluorescent protein, produced enhanced green fluorescent protein+ Ocls, further demonstrating that Ocls arise from HSCs. These Ocls express calcitonin and vitronectin receptors and tartrate-resistant acid phosphatase and possess the ability to resorb bone. Ocl formation in this assay is cell contact dependent and is independent of added exogenous factors. Conditioned medium from the coculture contained high levels of interleukin (IL)-6, IL-11, leukemia inhibitory factor (LIF), and macrophage-colony stimulating factor. IL-6 and LIF were present at low levels in cultures of hMSCs but undetectable in cultures of HSCs alone. These data suggest that coculture with HSCs induce hMSCs to secrete cytokines involved in Ocl formation. Addition of neutralizing anti-IL-6, IL-11, LIF, or macrophage-colony stimulating factor antibodies to the coculture inhibited Ocl formation. hMSCs seem to support Ocl formation as undifferentiated progenitor cells, because treatment of hMSCs with dexamethasone, ascorbic acid, and beta-glycerophosphate (to induce osteogenic differentiation) actually inhibited osteoclastogenesis in this coculture model. In conclusion, we have developed a simple and reproducible assay using culture-expanded hMSCs and purified HSCs with which to study the mechanisms of human osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433234     DOI: 10.1210/endo.140.8.6880

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

Review 1.  Hematopoietic stem cells: multiparameter regulation.

Authors:  Kedong Song; Liying Li; Yiwei Wang; Tianqing Liu
Journal:  Hum Cell       Date:  2016-02-16       Impact factor: 4.174

2.  Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Authors:  Changhui Zhou; Bo Yang; Yi Tian; Hongliang Jiao; Wendi Zheng; Jian Wang; Fangxia Guan
Journal:  Cell Immunol       Date:  2011-09-29       Impact factor: 4.868

3.  A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation.

Authors:  Shigeru Amano; Keisuke Sekine; Lynda F Bonewald; Yoshihiro Ohmori
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

4.  Improved methods for testing antiresorptive compounds in human osteoclast cultures.

Authors:  Jukka P Rissanen; Hannele Ylipahkala; Katja M Fagerlund; Clive Long; H Kalervo Väänänen; Jussi M Halleen
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

5.  Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol.

Authors:  G B Di Gregorio; M Yamamoto; A A Ali; E Abe; P Roberson; S C Manolagas; R L Jilka
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 6.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

7.  Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate.

Authors:  D Stefanik; J Sarin; T Lam; L Levin; P S Leboy; S O Akintoye
Journal:  Oral Dis       Date:  2008-07       Impact factor: 3.511

8.  Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.

Authors:  Manasa G Garimella; Supinder Kour; Vikrant Piprode; Monika Mittal; Anil Kumar; Lekha Rani; Satish T Pote; Gyan C Mishra; Naibedya Chattopadhyay; Mohan R Wani
Journal:  J Immunol       Date:  2015-11-04       Impact factor: 5.422

9.  Apoptotic mesenchymal stromal cells support osteoclastogenesis while inhibiting multinucleated giant cells formation in vitro.

Authors:  Paul Humbert; Meadhbh Á Brennan; Julien De Lima; Régis Brion; Annie Adrait; Céline Charrier; Bénédicte Brulin; Valérie Trichet; Yohann Couté; Frédéric Blanchard; Pierre Layrolle
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

Review 10.  Adult bone-marrow stem cells and their potential in medicine.

Authors:  H T Hassan; M El-Sheemy
Journal:  J R Soc Med       Date:  2004-10       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.